This inventor holds 1 USPTO granted patent. Top assignee: Oxford Finance LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 10 Years Active: 2026
Title: Jordan Jarjour: Innovator in Immunotherapy
Introduction
Jordan Jarjour is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of immunotherapy, particularly with his innovative approach to targeting CD33.
Latest Patents
Jordan holds a patent for "CD33 Targeted Immunotherapies." This patent represents a crucial advancement in the treatment of diseases, showcasing his commitment to improving healthcare through innovative solutions. He has 1 patent to his name.
Career Highlights
Jordan is currently employed at Oxford Finance LLC, where he applies his expertise in the financial aspects of healthcare innovations. His role allows him to bridge the gap between finance and medical advancements, ensuring that groundbreaking ideas receive the support they need to flourish.
Collaborations
Throughout his career, Jordan has collaborated with talented individuals such as Milton Ma and Mark Pogson. These partnerships have enabled him to enhance his research and expand the impact of his inventions.
Conclusion
Jordan Jarjour is a dedicated inventor whose work in immunotherapy is paving the way for future advancements in medical treatments. His contributions are vital to the ongoing evolution of healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile